News & Events
UCL Business spin-out Pentraxin Therapeutics awarded grant from the Wellcome Trust Seeding Drug Discovery Initiative
Professor Mark Pepys FRS FMedSci, a leading University College London (UCL) scientist, Head of Medicine at the Hampstead Campus (Royal Free), Director of the UCL Centre for Amyloidosis and Acute Phase Proteins, and Director of Pentraxin Therapeutics Ltd, has secured a major grant to develop breakthrough therapeutics in the treatment of transthyretin amyloidosis.
Full Story
UCL enhances London Genetics' partnering capabilities
Leading experts in genetics and genomics from UCL and six other academic institutions will provide insight into available expertise and resources in London and advise on project design.
Full Story
UCLB takes to the grid at Formula Student 2007
A team of mechanical engineering students from UCL, backed by UCL Business sponsorship, and led by senior lecturer Dr Kevin Drake and technician Neil Collings, has created a Class One entry in the Formula Student motor sport competition.
Full Story
Artificial Artery that keeps your blood pumping
"A man-made artery that behaves just like the real thing could transform heart bypass surgery. The British invention looks like a piece of spaghetti and is coated with a space-age that stops it from becoming blocked once it has been implanted."
Full Story
'Business Sense from Universities', Prof. Mike Spyer, Vice-Provost (Enterprise) UCL
.jpg)
UCL is London’s research powerhouse, with more than 3,500 academic and research staff in its science, technology, engineering and biomedical departments. In the most recent Research Assessment Exercise, 40 of our departments in these fields were rated ‘5’, ‘5*’ and ‘best 5*’.
Full Story
